anito-cel

Kite and Arcellx prepare to launch Phase III multiple myeloma trial
Clinical Trials Arena
Mon, 05/13/24 - 11:22 am
Kite Pharma
Gilead Sciences
Arcellx
clinical trials
anito-cel
Multiple Myeloma